[1] Wright JT, Fete M, Schneider H, et al.Ectodermal dysplasias: classification and organization by phenotype, genotype and molecular pathway[J]. Am J Med Genet A, 2019, 179(3): 442-447. [2] Nguyen-Nielsen M, Skovbo S, Svaneby D, et al.The prevalence of X-linked hypohidrotic ectodermal dysplasia (XLHED) in Denmark, 1995-2010[J]. Eur J Med Genet, 2013, 56(5): 236-242. [3] Anbouba GM, Carmany EP, Natoli JL.The characterization of hypodontia, hypohidrosis, and hypotrichosis associated with X-linked hypohidrotic ectodermal dysplasia: a systematic review[J]. Am J Med Genet A, 2020, 182(4): 831-841. [4] Blüschke G, Nüsken KD, Schneider H.Prevalence and prevention of severe complications of hypohidrotic ectodermal dysplasia in infancy[J]. Early Hum Dev, 2010, 86(7): 397-399. [5] Mikkola ML.Molecular aspects of hypohidrotic ectodermal dysplasia[J]. Am J Med Genet A, 2009, 149A(9): 2031-2036. [6] Guazzarotti L, Tadini G, Mancini G, et al.WNT10A gene is the second molecular candidate in a cohort of young Italian subjects with ectodermal derivative impairment[J]. Clin Genet, 2018, 93(3): 693-698. [7] Sadier A, Viriot L, Pantalacci S, et al.The ectodysplasin pathway: from diseases to adaptations[J]. Trends Genet, 2014, 30(1): 24-31. [8] Kowalczyk-Quintas C, Schneider P. Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation[J]. Cytokine Growth Factor Rev, 2014, 25(2): 195-203. [9] Trzeciak WH, Koczorowski R.Molecular basis of hypohidrotic ectodermal dysplasia: an update[J]. J Appl Genet, 2016, 57(1): 51-61. [10] Lin Y, Yin W, Bian Z.Mutation detection and prenatal diagnosis of XLHED pedigree[J]. PeerJ, 2017, 5: e3691. [11] Hammersen J, Wohlfart S, Goecke TW, et al.Reliability of prenatal detection of X-linked hypohidrotic ectodermal dysplasia by tooth germ sonography[J]. Prenat Diagn, 2019, 39(9): 796-805. [12] Reyes-Reali J, Mendoza-Ramos M, Garrido-Guerrero E, et al.Hypohidrotic ectodermal dysplasia: clinical and molecular review[J]. Int J Dermatol, 2018, 57(8): 965-972. [13] Schneider P, Street S, Gaide O, et al.Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A[J]. J Biol Chem, 2001, 276(22): 18819-18827. [14] Wang X, Zhang Z, Yuan S, et al.A novel EDA1 missense mutation in X-linked hypohidrotic ectodermal dysplasia[J]. Medicine (Baltimore), 2020, 99(11): e19244. [15] Liu G, Wang X, Qin M, et al.A novel missense mutation p.S305R of EDA gene causes XLHED in a Chinese family[J]. Arch Oral Biol, 2019, 107: 104507. [16] Chen Y, Molloy SS, Thomas L, et al.Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia[J]. Proc Natl Acad Sci USA, 2001, 98(13): 7218-7223. [17] Swee LK, Ingold-Salamin K, Tardivel A, et al.Biological activity of ectodysplasin A is conditioned by its collagen and heparan sulfate proteoglycan-binding domains[J]. J Biol Chem, 2009, 284(40): 27567-27576. [18] Bildik T, Ozbaran B, Kose S, et al.Hypohidrotic ectodermal dysplasia: a multidisciplinary approach[J]. Int J Psychiatry Med, 2012, 44(3): 225-240. [19] Schnabl D, Grunert I, Schmuth M, et al.Prosthetic rehabilitation of patients with hypohidrotic ectodermal dysplasia: a systematic review[J]. J Oral Rehabil, 2018, 45(7): 555-570. [20] Schneider H, Faschingbauer F, Schuepbach-Mallepell S, et al.Prenatal correction of X-linked hypohidrotic ectodermal dysplasia[J]. N Engl J Med, 2018, 378(17): 1604-1610. |